IM Cannabis Corp (TSE:IMCC) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
IM Cannabis Corp. reported a substantial 50% revenue growth in Q3 2024 for its German subsidiary, Adjupharm GmbH, following the partial legalization of cannabis in Germany earlier that year. The company attributes this success to its strategic initiatives and a robust supply chain that meets the rising demand for cannabis products. IM Cannabis Corp. is an international player focused on providing premium cannabis to the medical markets in Israel and Germany, building on a data-driven approach and a global supply chain.
For further insights into TSE:IMCC stock, check out TipRanks’ Stock Analysis page.
